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Background
HIV-1 infection generates numerous abnormalities in the
B cell population. The majority of these defects are
reverted by antiretroviral therapy. Our aim was to evaluate
the effects of re-exposure to HIV antigens on the fre-
quency and functionality of antibody secreting cells (ASC)
in patients undergoing structured treatment interruptions
(STI). As re-exposure to viral antigens may also boost the
production of (neutralizing) antibodies, we also assessed
the neutralizing activities during STI cycles.
Methods
Retrospective study of 10 patients undergoing 3 cycles of
STI with 2 weeks on and 4 weeks off HAART. ASC fre-
quencies were determined by flow cytometry in samples
obtained at the beginning and the end of STI. Neutraliza-
tion capacity, total IgG concentration and anti-gp120-IgG
titres were evaluated.
Results
Median viral loads were higher at the end of STI com-
pared to time of treatment stop: 20[20-1200] vs 615[20-
452000] respectively for the first STI, 20[20-654] vs 3655
[20-45900] (p<0.05) for the second and 35[20-82] vs 290
[20-17400] (p<0.05) for the third STI. The frequency of
ASC followed the same trend: 0.35%[0.17-1.15] at the
beginning of first STI vs 0.27[0.20-4.95] at treatment
restart, 0.35[0.10-1.40] vs 0.82[0.30-3.25] for the second
and 0.30[0.10-0.70] vs 0.40[0.15-1.85] for the third STI.
Eight out of 10 patients maintained stable total IgG levels
during the study. HIV-neutralizing activity was observed
in two patients concomitantly with high anti-gp120 titters.
In one patient the neutralizing activity remained constant
while the second patient showed elevated neutralizing Ab
after first STI and once treatment was reinitiated after the
2nd STI.
Conclusion
Our data suggest that STI and its associated transient
increases in viral load drive the frequencies of ASC in an
antigen-specific manner. In some subjects, this re-expo-
sure to autologous virus boosts the presence of neutraliz-
ing antibodies, albeit in a somewhat delayed manner.
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